It enables every actor in Pathology to run digital image analysis in the context of clinical trials, as in CAP/CLIA laboratories, with unprecedented efficiency. This AI-platform strengthens Keen Eye's strategic positioning in the clinical...

JOIN THE LIVE WEBINAR Date and time : June 2, 2021 at 11:00am (EDT)/5:00pm (CET) Exploiting digital histology approaches to probe the pathophysiology of SARS-CoV-2 infection Register Now COVID-19 is a complex multi-phase disease. In most...

Digital pathology is undergoing a revolutionary change with the introduction of state-of-the-art pattern recognition via/with deep learning. The transition from feature engineering and classical machine learning to end-to-end deep learning have...

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Flagship Biosciences, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. “CAP...

April 16, 2015, Westminster CO — Flagship Biosciences, the leading service provider of digital pathology solutions, announced today the utilization of its wet assay development and image analysis quantification capabilities for RNAscope®...

CAMBRIDGE, Mass., Aug 20, 2014 -- Sarepta Therapeutics, Inc, a developer of innovative RNA-based therapeutics, and Flagship Biosciences LLC, a leading digital pathology firm, today announced a multi-year, multi-product partnership for the...